StockClub
MISTMilestone Pharmaceuticals Inc.$ --
Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

MIST

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
2M USD
-

Operating Income

bar_chart
-62M USD
YoY -48.4%

Net Income

verified
-63M USD
YoY -51.9%

EPS

pie_chart
-0.75USD
YoY -11.9%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress77.7%On Track
Revenue Progress238,000
Revenue Forecast53.6M
Net Income Progress-26.1M
Net Income Forecast-33.6M

Income Statement Details

Item
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
2
0
1
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
18
0
17
64
-62
Interest expense
Income before tax
Income tax expense
Net income
4
-63
-0
-63

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.